by Long Fu Xi, Mingjun Jiang, Zhenping Shen, Ayaka Hulbert, Xiao-Hua Zhou, Ying-Ying Lin, Nancy B. Kiviat, Laura A. Koutsky
The clinical relevance of human papillomavirus type 16 (HPV16) DNA methylation has not been well documented, although its role in modulation of viral transcription is recognized. Methods
Study subjects were 211 women attending Planned Parenthood clinics in Western Washington for routine Papanicolaou screening who were HPV16 positive at the screening and/or subsequent colposcopy visit. Methylation of 11 CpG dinucleotides in the 3' end of the long control region of the HPV16 genome was examined by sequencing the cloned polymerase chain reaction products. The association between risk of CIN2/3 and degree of CpG methylation was estimated using a logistic regression model. Results
CIN2/3 was histologically confirmed in 94 (44.5%) of 211 HPV16 positive women. The likelihood of being diagnosed as CIN2/3 increased significantly with decreasing numbers of methylated CpGs (meCpGs) in the 3' end of the long control region (Pfor trend?=?0.003). After adjusting for HPV16 variants, number of HPV16-positive visits, current smoking status and lifetime number of male sex partners, the odds ratio for the association of CIN2/3 with =4 meCpGs was 0.31 (95% confidence interval, 0.12–0.79). The proportion of =4 meCpGs decreased appreciably as the severity of the cervical lesion increased (Pfor trend?=?0.001). The inverse association remained similar when CIN3 was used as the clinical endpoint. Although not statistically significant, the =4 meCpGs-related risk reduction was more substantial among current, as compared to noncurrent, smokers. Conclusion
Results suggest that degree of the viral genome methylation is related to the outcome of an HPV16 cervical infection.